GENEDIA wins CE Marking, KGC Sang-A says

Published: 2004-02-04 06:56:00

Updated: 2004-02-04 06:56:00

Korea Green Cross Sang-A said on February 2 that its GENEDIA HBsAg ELISA 3.0, hepatitis B surface antigen diagnostic product, received a CE marking from Germany-based TUV Product Service GmbH, known as one of the world's leading international organizations for testing, evaluation and certificatio...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK